Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study
Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study
Mycobacterium tuberculosis is the bacterial strain that causes tuberculosis (TB). However, multidrug-resistant and extensively drug-resistant tuberculosis are significant obstacles to effective treatment. As a result, novel therapies against various strains of
M. tuberculosis have been developed. Drug development is a lengthy procedure that includes identifying target protein and isolation, preclinical testing of the drug, and various phases of a clinical trial,
etc., can take decades for a molecule to reach the market. Computational approaches such as QSAR, molecular docking techniques, and pharmacophore modeling have aided drug development. In this review article, we have discussed the various techniques in tuberculosis drug discovery by briefly introducing them and their importance. Also, the different databases, methods, approaches, and software used in conducting QSAR, pharmacophore modeling, and molecular docking have been discussed. The other targets targeted by these techniques in tuberculosis drug discovery have also been discussed, with important molecules discovered using these computational approaches. This review article also presents the list of drugs in a clinical trial for tuberculosis found drugs. Finally, we concluded with the challenges and future perspectives of these techniques in drug discovery.
Bhowmik, Ratul
d8454d94-6e41-4a4d-b712-cbc06850c488
Kant, Ravi
7701bda0-8d8b-4c7b-b988-75f6da612e2a
Manaithiya, Ajay
7945d758-d06e-4b7c-9a53-818c25f4d832
Saluja, Daman
c632b624-e87e-4d82-a045-5e3af0dd8439
Vyas, Bharti
85ee0ddf-33c4-4ae7-bfda-a905be93d67c
Nath, Ranajit
1257a93c-66ce-4a4a-8533-56bdf056946c
Qureshi, Kamal A
5e2095d8-1828-4e22-8287-938196c322f6
Parkkila, Seppo
2f5312e1-ca70-4c58-993b-25aea9fe524f
Aspatwar, Ashok
b2718c78-c998-48a8-b193-1a5ade1c0b2c
29 August 2023
Bhowmik, Ratul
d8454d94-6e41-4a4d-b712-cbc06850c488
Kant, Ravi
7701bda0-8d8b-4c7b-b988-75f6da612e2a
Manaithiya, Ajay
7945d758-d06e-4b7c-9a53-818c25f4d832
Saluja, Daman
c632b624-e87e-4d82-a045-5e3af0dd8439
Vyas, Bharti
85ee0ddf-33c4-4ae7-bfda-a905be93d67c
Nath, Ranajit
1257a93c-66ce-4a4a-8533-56bdf056946c
Qureshi, Kamal A
5e2095d8-1828-4e22-8287-938196c322f6
Parkkila, Seppo
2f5312e1-ca70-4c58-993b-25aea9fe524f
Aspatwar, Ashok
b2718c78-c998-48a8-b193-1a5ade1c0b2c
Bhowmik, Ratul, Kant, Ravi, Manaithiya, Ajay, Saluja, Daman, Vyas, Bharti, Nath, Ranajit, Qureshi, Kamal A, Parkkila, Seppo and Aspatwar, Ashok
(2023)
Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study.
Frontiers in Pharmacology, 14, [1265573].
(doi:10.3389/fphar.2023.1265573).
Abstract
Mycobacterium tuberculosis is the bacterial strain that causes tuberculosis (TB). However, multidrug-resistant and extensively drug-resistant tuberculosis are significant obstacles to effective treatment. As a result, novel therapies against various strains of
M. tuberculosis have been developed. Drug development is a lengthy procedure that includes identifying target protein and isolation, preclinical testing of the drug, and various phases of a clinical trial,
etc., can take decades for a molecule to reach the market. Computational approaches such as QSAR, molecular docking techniques, and pharmacophore modeling have aided drug development. In this review article, we have discussed the various techniques in tuberculosis drug discovery by briefly introducing them and their importance. Also, the different databases, methods, approaches, and software used in conducting QSAR, pharmacophore modeling, and molecular docking have been discussed. The other targets targeted by these techniques in tuberculosis drug discovery have also been discussed, with important molecules discovered using these computational approaches. This review article also presents the list of drugs in a clinical trial for tuberculosis found drugs. Finally, we concluded with the challenges and future perspectives of these techniques in drug discovery.
This record has no associated files available for download.
More information
Accepted/In Press date: 10 August 2023
Published date: 29 August 2023
Additional Information:
Copyright © 2023 Bhowmik, Manaithiya, Vyas, Nath, Qureshi, Parkkila and Aspatwar.
Identifiers
Local EPrints ID: 501552
URI: http://eprints.soton.ac.uk/id/eprint/501552
ISSN: 1663-9812
PURE UUID: 6c0e1532-d3be-4ef6-9b26-9cc85a14cbd4
Catalogue record
Date deposited: 03 Jun 2025 17:00
Last modified: 04 Jun 2025 02:13
Export record
Altmetrics
Contributors
Author:
Ratul Bhowmik
Author:
Ravi Kant
Author:
Ajay Manaithiya
Author:
Daman Saluja
Author:
Bharti Vyas
Author:
Ranajit Nath
Author:
Kamal A Qureshi
Author:
Seppo Parkkila
Author:
Ashok Aspatwar
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics